| Erin Olivia Clark, | |
|
1601 Owen Dr, Fayetteville, NC 28304-3425 | |
| (910) 678-0100 | |
| Not Available |
| Full Name | Erin Olivia Clark |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 1601 Owen Dr, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134680325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 2021-02324 (North Carolina) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191001003503 |
News Archive
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causal agent of the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more than 4.3 million lives worldwide. Even after implementing various measures, such as vaccination and social restrictions, SARS-CoV-2 and its variants of concern (VoC) leave the world's public health systems and economies in turmoil.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as "aggregate spend" reporting regulations.
A group of researchers from EPFL's Global Health Institute and Inserm has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.
A latest device that looks like a watch "could revolutionize blood pressure monitoring". The device tied to the wrist can estimate pressure in the aorta, the largest artery in the body.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Olivia Clark, 1601 Owen Dr, Fayetteville, NC 28304-3425 Ph: (910) 678-0100 | Erin Olivia Clark, 1601 Owen Dr, Fayetteville, NC 28304-3425 Ph: (910) 678-0100 |
News Archive
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causal agent of the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more than 4.3 million lives worldwide. Even after implementing various measures, such as vaccination and social restrictions, SARS-CoV-2 and its variants of concern (VoC) leave the world's public health systems and economies in turmoil.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as "aggregate spend" reporting regulations.
A group of researchers from EPFL's Global Health Institute and Inserm has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria.
A latest device that looks like a watch "could revolutionize blood pressure monitoring". The device tied to the wrist can estimate pressure in the aorta, the largest artery in the body.
› Verified 7 days ago